miércoles, 30 de agosto de 2017

Press Announcements > FDA approves new antibacterial drug

Press Announcements > FDA approves new antibacterial drug

u s food and drug administration

08/29/2017 05:56 PM EDT


The U.S. Food and Drug Administration today approved Vabomere for adults with complicated urinary tract infections (cUTI), including a type of kidney infection, pyelonephritis, caused by specific bacteria. Vabomere is a drug containing meropenem, an antibacterial, and vaborbactam, which inhibits certain types of resistance mechanisms used by bacteria.

No hay comentarios:

Publicar un comentario